Skip to main content
Schedule
Full Agenda
Browse by Date
Thursday, October 15, 2020
Friday, October 16, 2020
Saturday, October 17, 2020
Sunday, October 18, 2020
Monday, October 19, 2020
Tuesday, October 20, 2020
Wednesday, October 21, 2020
Thursday, October 22, 2020
Friday, October 23, 2020
Monday, October 26, 2020
Tuesday, October 27, 2020
Wednesday, October 28, 2020
Thursday, October 29, 2020
Friday, October 30, 2020
Saturday, October 31, 2020
Sunday, November 1, 2020
Monday, November 2, 2020
Tuesday, November 3, 2020
Wednesday, November 4, 2020
Thursday, November 5, 2020
Friday, November 6, 2020
Browse by Title
Poster Wall
Toggle navigation
Search
Home
Schedule
Full Agenda
Browse by Date
Thursday, October 15, 2020
Friday, October 16, 2020
Saturday, October 17, 2020
Sunday, October 18, 2020
Monday, October 19, 2020
Tuesday, October 20, 2020
Wednesday, October 21, 2020
Thursday, October 22, 2020
Friday, October 23, 2020
Monday, October 26, 2020
Tuesday, October 27, 2020
Wednesday, October 28, 2020
Thursday, October 29, 2020
Friday, October 30, 2020
Saturday, October 31, 2020
Sunday, November 1, 2020
Monday, November 2, 2020
Tuesday, November 3, 2020
Wednesday, November 4, 2020
Thursday, November 5, 2020
Friday, November 6, 2020
Browse by Title
Poster Wall
Tweets by JADPRO Live 2020 Virtual
238 Views
Back
0
Like
Facebook
Tweet
Print
JADPRO Live 2020
Encore
FDA and its Role in Drug Development (Live Q&A not available)
Monday, October 19, 2020
10:00 AM – 10:30 AM EDT
Location: Auditorium
Speaker(s)
Richard Pazdur, MD
US Food and Drug Organization
Please note that live Q&A is not available for this Encore presentation.
.50 pharmacology credits available
Learning Objectives:
Discuss recent changes to the oncology drug development and approval process
Describe the role of the AP in the execution of clinical trials
Identify 3 changes that have taken place in the FDA's drug development and approval process as a result of the COVID-19 pandemic
